Departments of Obstetrics and Gynecology of Northwestern University, Chicago, IL (Miller).
The Ohio State University, Columbus, OH (Costantine).
Am J Obstet Gynecol MFM. 2024 Nov;6(11):101488. doi: 10.1016/j.ajogmf.2024.101488. Epub 2024 Sep 16.
Perinatal depression has been suggested to adversely impact child neurodevelopment. However, the complexity of the early childhood environment challenges conclusive findings.
To evaluate whether there is an association between perinatal depressive symptoms and child intelligence quotient (IQ) at 5 years of age.
Secondary analysis of an ancillary study to a multicenter randomized trial of thyroxine therapy for pregnant individuals with subclinical hypothyroidism. Dyads of infants and birthing parent, with completed Center for Epidemiological Studies-Depression (CES-D) screens during pregnancy and postpartum and child neurodevelopment testing completed at five years of age (n=209) were included. CES-D screening was performed at 11-20 weeks, 34-38 weeks, and one-year postpartum. Depressive symptoms were categorized as antenatal (i.e., a positive screen at any point during pregnancy) or postpartum. The primary outcome was child IQ score < 85 at 5 years of age using the Wechsler Preschool and Primary Scale of Intelligence III (WPPSI-III) Full Scale test. Secondary outcomes included other assessments of childhood neurodevelopment. Bivariable analyses and multivariable logistic regressions were utilized.
Of the 209 birthing people included, 72 (34%) screened positive for depression during pregnancy and 32 (15%) screened positive one year postpartum. Children born to individuals with a positive antenatal depression screen had a higher odds of IQ < 85 at 5 years of age compared with children born to individuals with a CES-D < 16 (35% vs. 18%, OR 2.4, 95% CI 1.2-4.7). Similar findings were seen for children born to individuals with a positive postpartum depression screen (47% vs. 21%, OR 3.3, 95% CI 1.5-7.3). These associations did not persist in multivariable analyses that controlled for social determinants of health and clinical characteristics (adjusted odd ratio [aOR] 1.4, 95% CI 0.7-3.1; aOR 2.1, 95% CI 0.9-5.1, for antenatal and postpartum depressive symptoms, respectively). Similar findings were observed for other adverse neurodevelopmental outcomes.
Having a positive perinatal depression screen was not associated with child cognitive outcomes after controlling for covariates including social determinants of health.
围产期抑郁被认为会对儿童神经发育产生不利影响。然而,幼儿期环境的复杂性使得结论难以确定。
评估围产期抑郁症状与 5 岁儿童智商(IQ)之间是否存在关联。
这是一项多中心随机试验的辅助研究的二次分析,该试验针对亚临床甲状腺功能减退症孕妇进行甲状腺素治疗。纳入了在妊娠和产后期间完成了中心流行病学研究-抑郁(CES-D)筛查且在 5 岁时完成了儿童神经发育测试的母婴对子(n=209)。CES-D 筛查在 11-20 周、34-38 周和产后 1 年进行。将抑郁症状分为产前(即怀孕期间任何时候筛查阳性)或产后。主要结局是使用韦氏学前和小学智力量表 III(WPPSI-III)全量表测试,5 岁时儿童智商得分<85。次要结局包括其他儿童神经发育评估。采用单变量分析和多变量逻辑回归进行分析。
在纳入的 209 名产妇中,有 72 名(34%)在妊娠期间筛查出抑郁,32 名(15%)在产后 1 年筛查出抑郁。与 CES-D<16 的产妇所生儿童相比,产前抑郁筛查阳性产妇所生儿童在 5 岁时智商<85 的可能性更高(35%比 18%,OR 2.4,95%CI 1.2-4.7)。产后抑郁筛查阳性产妇所生儿童也有类似的发现(47%比 21%,OR 3.3,95%CI 1.5-7.3)。在控制健康的社会决定因素和临床特征的多变量分析中,这些关联并未持续存在(调整后的比值比[aOR] 1.4,95%CI 0.7-3.1;aOR 2.1,95%CI 0.9-5.1,分别用于产前和产后抑郁症状)。对于其他不良神经发育结局,也有类似的发现。
在控制包括健康的社会决定因素在内的协变量后,产前抑郁筛查阳性与儿童认知结局无关。